ADMA Biologics Inc ADMA
$9.86 $0.05 (0.50%) 1D
Last Updated: Aug 12, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
ADMA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, ADMA Biologics Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
ADMA Biologics Inc. Stock Analysis ADMA
United States Health Care Mid Cap ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 647 full-time employees. The company went IPO on 2013-10-17. The firm manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
ADMA Biologics Inc (ADMA) Chart
Financial Metrics & Statements of ADMA Biologics Inc (ADMA)
FAQ's for ADMA Biologics Inc (ADMA)
- As of August 2026, ADMA Biologics Inc ADMA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ADMA Biologics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in ADMA Biologics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of ADMA Biologics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of ADMA Biologics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of ADMA Biologics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to ADMA Biologics Inc (ADMA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
